Invention Grant
- Patent Title: Somatostatin subtype-2 receptor (SST2R) targeted therapeutics and uses thereof
-
Application No.: US18434159Application Date: 2024-02-06
-
Publication No.: US12134610B2Publication Date: 2024-11-05
- Inventor: Jian Zhao , Yunfei Zhu , Mi Chen
- Applicant: Crinetics Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: Crinetics Pharmaceuticals, Inc.
- Current Assignee: Crinetics Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Diego
- Agency: WILSON SONSINI GOODRICH & ROSATI
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61P35/00 ; C07D405/14 ; C07D491/22 ; C07D498/04
Abstract:
Described herein are somatostatin subtype-2 receptor (SST2R) targeted therapeutics that target tumor cells expressing SST2R and their use in the treatment of cancer.
Public/Granted literature
- US20240254105A1 SOMATOSTATIN SUBTYPE-2 RECEPTOR (SST2R) TARGETED THERAPEUTICS AND USES THEREOF Public/Granted day:2024-08-01
Information query
